BRAFV600E melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BRAFV600E melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 111, Issue 8, Pages 1625-1633
Publisher
Springer Nature
Online
2014-08-13
DOI
10.1038/bjc.2014.452
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Emerging Role of the Thrombin Receptor (PAR-1) in Melanoma Metastasis - a Possible Therapeutic Target
- (2015) Gabriel J. Villares et al. Oncotarget
- BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
- (2013) D. T. Frederick et al. CLINICAL CANCER RESEARCH
- Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases
- (2013) Luigi Portella et al. PLoS One
- TGF-β Signaling, Activated Stromal Fibroblasts, and Cysteine Cathepsins B and L Drive the Invasive Growth of Human Melanoma Cells
- (2012) Miao Yin et al. AMERICAN JOURNAL OF PATHOLOGY
- Matrix metalloproteases and PAR1 activation
- (2012) K. M. Austin et al. BLOOD
- BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy
- (2012) Richard C. Koya et al. CANCER RESEARCH
- Oncogenic BRAF(V600E) Promotes Stromal Cell-Mediated Immunosuppression Via Induction of Interleukin-1 in Melanoma
- (2012) J. S. Khalili et al. CLINICAL CANCER RESEARCH
- A review on CXCR4/CXCL12 axis in oncology: No place to hide
- (2012) Urszula M. Domanska et al. EUROPEAN JOURNAL OF CANCER
- The extracellular matrix: A dynamic niche in cancer progression
- (2012) Pengfei Lu et al. JOURNAL OF CELL BIOLOGY
- Differential mechanisms of tumor progression in clones from a single heterogeneous human melanoma
- (2012) Walburga Croteau et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The role of BRAF V600 mutation in melanoma
- (2012) Paolo A Ascierto et al. Journal of Translational Medicine
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- MAP kinase signaling and inhibition in melanoma
- (2012) R J Sullivan et al. ONCOGENE
- Melanoma-derived conditioned media efficiently induce the differentiation of monocytes to macrophages that display a highly invasive gene signature
- (2012) Tao Wang et al. Pigment Cell & Melanoma Research
- Melanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistance
- (2012) Hubing Shi et al. Nature Communications
- PAR-1 and Thrombin: The Ties That Bind the Microenvironment to Melanoma Metastasis
- (2011) M. Zigler et al. CANCER RESEARCH
- Matrix metalloproteinases in tumorigenesis: an evolving paradigm
- (2011) Hui Hua et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Targeting BRAF in Advanced Melanoma: A First Step toward Manageable Disease
- (2011) A. Vultur et al. CLINICAL CANCER RESEARCH
- Immunomodulatory cytokines as therapeutic agents for melanoma
- (2011) Courtney Nicholas et al. Immunotherapy
- Global Analysis of BRAFV600E Target Genes in Human Melanocytes Identifies Matrix Metalloproteinase-1 as a Critical Mediator of Melanoma Growth
- (2011) Byungwoo Ryu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function
- (2010) A. Boni et al. CANCER RESEARCH
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines
- (2010) Wiltrud Lederle et al. INTERNATIONAL JOURNAL OF CANCER
- Meenhard Herlyn
- (2010) Ruth Halaban Pigment Cell & Melanoma Research
- Interleukin-1 (IL-1 ) Processing Pathway
- (2010) A. Weber et al. Science Signaling
- Interleukin-1 (IL-1) Pathway
- (2010) A. Weber et al. Science Signaling
- The chemokine system in cancer biology and therapy
- (2009) Alberto Mantovani et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Crosstalk between Protease-activated Receptor 1 and Platelet-activating Factor Receptor Regulates Melanoma Cell Adhesion Molecule (MCAM/MUC18) Expression and Melanoma Metastasis
- (2009) Vladislava O. Melnikova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CXCR4 and Matrix Metalloproteinase-1 Are Elevated in Breast Carcinoma-Associated Fibroblasts and in Normal Mammary Fibroblasts Exposed to Factors Secreted by Breast Cancer Cells
- (2009) S. M. Eck et al. MOLECULAR CANCER RESEARCH
- A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis
- (2009) J S Blackburn et al. ONCOGENE
- Matrix Metalloproteinase-1 and Thrombin Differentially Activate Gene Expression in Endothelial Cells via PAR-1 and Promote Angiogenesis
- (2008) Jessica S. Blackburn et al. AMERICAN JOURNAL OF PATHOLOGY
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- Is interleukin-1 a good or bad ‘guy’ in tumor immunobiology and immunotherapy?
- (2008) Ron N. Apte et al. IMMUNOLOGICAL REVIEWS
- A novel B-RAF inhibitor blocks interleukin-8 (IL-8) synthesis in human melanoma xenografts, revealing IL-8 as a potential pharmacodynamic biomarker
- (2008) S. Crawford et al. MOLECULAR CANCER THERAPEUTICS
- Melanoma and the tumor microenvironment
- (2008) Jessie Villanueva et al. Current Oncology Reports
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now